サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1399279

止血材の世界市場：用途別、エンドユーザー別、タイプ別、製剤と14カ国以上のデータ- 2024-2033年の分析・予測

Global Hemostats Market: Focus on Applications, End User, Types, Formulation and Over 14 Countries' Data - Analysis and Forecast, 2024-2033
出版日: | 発行: BIS Research | ページ情報: 英文 155 Pages | 納期: 1～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
止血材の世界市場：用途別、エンドユーザー別、タイプ別、製剤と14カ国以上のデータ- 2024-2033年の分析・予測
出版日: 2023年12月26日
発行: BIS Research
ページ情報: 英文 155 Pages
納期: 1～5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の止血材の市場は、外科手術の増加と技術の進歩に牽引され、目覚ましい成長を示すと予測されています。

当レポートでは、世界の止血材の市場を調査し、市場の背景・概要、市場成長への各種影響因子の分析、法規制環境、R&D・特許の動向、市場規模の推移・予測、地域/主要国別の詳細分析、主要企業の分析などをまとめています。

目次

エグゼクティブサマリー

範囲と定義

第1章 市場

  • 動向：現在および将来の影響評価
  • サプライチェーンの概要
    • バリューチェーン分析
    • 市場マップ
    • 原材料・部品の価格予測
  • R&Dレビュー
    • 特許出願動向 (国・企業別)
  • 規制状況
  • 主要な世界的出来事の影響分析：COVID-19
  • 市場力学の概要
    • 市場促進要因
    • 市場抑制要因
    • 市場機会

第2章 用途

  • 用途の分類
  • 用途の概要
  • 世界の止血材市場 (用途別)
    • 心臓血管外科
    • 一般外科
    • 婦人科外科
    • 整形外科
    • 神経外科
    • その他
  • 世界の止血材市場 (エンドユーザー別)
    • 病院
    • 外来手術センター
    • クリニック・医師のオフィス
    • その他

第3章 製品

  • 製品の分類
  • 製品概要
  • 世界の止血材市場 (タイプ別)
    • 市場概要
  • 世界の止血材市場 (タイプ別)
    • 酸化再生セルロースベース
    • トロンビンベース
    • コンビネーション
    • ゼラチンベース
    • コラーゲンベース
    • その他
  • 世界の止血材市場 (製剤別)
    • マトリックス・ゲル
    • シート・パッド
    • スポンジ
    • 粉末

第4章 地域

  • 地域概要
  • 促進要因・抑制要因
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • その他の地域

第5章 市場：競合ベンチマーキング・企業プロファイル

  • 次のフロンティア
  • 地理的評価
    • Pfizer Inc. plc
    • Baxter International
    • B. Braun Holding GmbH & Co. KG
    • Teleflex Incorporated
    • Medtronic
    • Stryker Corporation
    • Boston Scientific Corporation
    • Samyang Holdings Corporation
    • Advanced Medical Solutions Group plc
    • Integra Life Sciences
    • Hemostasis, LLC.
    • Johnson and Johnson
    • Altaylar Medical
    • Anika Therapeutics, Inc.
    • Cryolife, Inc.

第6章 調査手法

図表

List of Figures

  • Figure 1. Region/country Largest Share of Market
  • Figure 2. Pricing/Cost Analysis by Region, Supply Chain
  • Figure 3. Global Hemostats Market, by End User, 2022, 2026 and 2033
  • Figure 4. Global Hemostats Market, by Application, 2022, 2026 and 2033
  • Figure 5. Global Hemostats Market, by Product, 2022, 2026 and 2033
  • Figure 6. Global Hemostats Market, by Formulation, 2022, 2026 and 2033
  • Figure 7. Global Hemostats Market, Recent Developments
  • Figure 8. Supply chain and Identifying Risks within the Supply Chain
  • Figure 9. Global Hemostats Market, Patent Analysis, by Country, January 2020-December 2023
  • Figure 10. Global Hemostats Market, Patent Analysis, by Company, January 2020-December 2023
  • Figure 11. Impact Analysis of Market Navigating Factors
  • Figure 12. U.S. Hemostats Market, By Application ($ Million), 2022, 2026 and 2033
  • Figure 13. Canada Hemostats Market, By Application ($ Million), 2022, 2026 and 2033
  • Figure 14. France Hemostats Market, By Application ($ Million), 2022, 2026 and 2033
  • Figure 15. Germany Hemostats Market, By Application ($ Million), 2022, 2026 and 2033
  • Figure 16. U.K. Hemostats Market, By Application ($ Million), 2022, 2026 and 2033
  • Figure 17. Italy Hemostats Market, By Application ($ Million), 2022, 2026 and 2033
  • Figure 18. Spain Hemostats Market, By Application ($ Million), 2022, 2026 and 2033
  • Figure 19. Rest of Europe Hemostats Market, By Application ($ Million), 2022, 2026 and 2033
  • Figure 20. China Hemostats Market, By Application ($ Million), 2022, 2026 and 2033
  • Figure 21. India Hemostats Market, By Application ($ Million), 2022, 2026 and 2033
  • Figure 22. Japan Hemostats Market, By Application ($ Million), 2022, 2026 and 2033
  • Figure 23. Australia Hemostats Market, By Application ($ Million), 2022, 2026 and 2033
  • Figure 24. Rest-of-Asia Pacific Hemostats Market, By Application ($ Million), 2022, 2026 and 2033
  • Figure 25. Argentina Hemostats Market, By Application ($ Million), 2022, 2026 and 2033
  • Figure 26. Brazil Hemostats Market, By Application ($ Million), 2022, 2026 and 2033
  • Figure 27. Mexico Hemostats Market, By Application ($ Million), 2022, 2026 and 2033
  • Figure 28. Rest-of-Latin America Hemostats Market, By Application ($ Million), 2022, 2026 and 2033
  • Figure 29. Strategic Initiatives, 2020 - 2023
  • Figure 30. Share of Strategic Initiatives
  • Figure 31. Data Triangulation
  • Figure 32. Top-Down and Bottom-Up Approach
  • Figure 33. Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Global Hemostats Market, Opportunities
  • Table 3: Global Hemostats Market, by Type, $Million, 2023-2033
  • Table 4: Global Hemostats Market, By Region, ($ Million), 2022-2033
  • Table 5: North America Hemostats Market, By Application ($ Million), 2022-2033
  • Table 6: North America Hemostats Market, By End User ($ Million), 2022-2033
  • Table 7: North America Hemostats Market, By Type ($ Million), 2022-2033
  • Table 8: North America Hemostats Market, By Formulation ($ Million), 2022-2033
  • Table 9: U.S. Hemostats Market, By Application ($ Million), 2022-2033
  • Table 10: Canada Hemostats Market, By Application ($ Million), 2022-2033
  • Table 11: Europe Hemostats Market, By Application ($ Million), 2022-2033
  • Table 12: Europe Hemostats Market, By End User ($ Million), 2022-2033
  • Table 13: Europe Hemostats Market, By Type ($ Million), 2022-2033
  • Table 14: Europe Hemostats Market, By Formulation ($ Million), 2022-2033
  • Table 15: France Hemostats Market, By Application ($ Million), 2022-2033
  • Table 16: Germany Hemostats Market, By Application ($ Million), 2022-2033
  • Table 17: U.K. Hemostats Market, By Application ($ Million), 2022-2033
  • Table 18: Italy Hemostats Market, By Application ($ Million), 2022-2033
  • Table 19: Spain Hemostats Market, By Application ($ Million), 2022-2033
  • Table 20: Rest of Europe Hemostats Market, By Application ($ Million), 2022-2033
  • Table 21: Asia Pacific Hemostats Market, By Application ($ Million), 2022-2033
  • Table 22: Asia Pacific Hemostats Market, By End User ($ Million), 2022-2033
  • Table 23: Asia Pacific Hemostats Market, By Type ($ Million), 2022-2033
  • Table 24: Asia Pacific Hemostats Market, By Formulation ($ Million), 2022-2033
  • Table 25: China Hemostats Market, By Application ($ Million), 2022-2033
  • Table 26: India Hemostats Market, By Application ($ Million), 2022-2033
  • Table 27: Japan Hemostats Market, By Application ($ Million), 2022-2033
  • Table 28: Australia Hemostats Market, By Application ($ Million), 2022-2033
  • Table 29: Rest-of-Asia Pacific Hemostats Market, By Application ($ Million), 2022-2033
  • Table 30: Latin America Hemostats Market, By Application ($ Million), 2022-2033
  • Table 31: Latin America Hemostats Market, By End User ($ Million), 2022-2033
  • Table 32: Latin America Hemostats Market, By Type ($ Million), 2022-2033
  • Table 33: Latin America Hemostats Market, By Formulation ($ Million), 2022-2033
  • Table 34: Argentina Hemostats Market, By Application ($ Million), 2022-2033
  • Table 35: Brazil Hemostats Market, By Application ($ Million), 2022-2033
  • Table 36: Mexico Hemostats Market, By Application ($ Million), 2022-2033
  • Table 37: Rest-of-Latin America Hemostats Market, By Application ($ Million), 2022-2033
  • Table 38: Rest-of-the-World Hemostats Market, By Application ($ Million), 2022-2033
  • Table 39: Rest-of-the-World Hemostats Market, By End User ($ Million), 2022-2033
  • Table 40: Rest-of-the-World Hemostats Market, By Type ($ Million), 2022-2033
  • Table 41: Rest-of-the-World Hemostats Market, By Formulation ($ Million), 2022-2033
  • Table 42: Market Share
目次
Product Code: BHM1717SA

“Global Hemostats Market Poised for Remarkable Growth, Driven by Rising Surgical Procedures and Technological Advancements.”

The hemostats market report provides a comprehensive analysis of the global market for hemostats products. The report contains crucial statistics concerning the status of prominent players in the hemostats market, highlighting key trends and potential opportunities within the market.

The report provides an analysis of the driving and restraining factors affecting market growth. This includes factors like technological advancements, and regulatory policies impacting the hemostats market. This report presents an extensive overview of the industry, encompassing both qualitative and quantitative data.

Furthermore, the report scrutinizes factors impacting the hemostats market from both the demand and supply sides. The report includes the detailed profiles of key players in the hemostats market. This section includes information on company profiles, product portfolios, market strategies, mergers and acquisitions, and their position in the market. The overall aim of this report is to provide stakeholders, businesses, investors, and researchers with a comprehensive understanding of hemostats market.

Market Segmentation:

Segmentation 1: by Application

  • Cardiovascular Surgery
  • General Surgery
  • Gynecological Surgery
  • Orthopedic Surgery
  • Neurological Surgery
  • Others

Segmentation 2: by End User

  • Hospitals
  • Ambulatory Surgical Centres
  • Clinics and Physicans' Offices
  • Others

Segmentation 3: by Type

  • Oxidized Regenerated Cellulose-Based Hemostats
  • Thrombin Based Hemostats
  • Combination Hemostats
  • Gelatin-Based Hemostats
  • Collagen-Based Hemostats
  • Others

Segmentation 4: by Formulation

  • Matrix and Gel Hemostats
  • Sheet and Pad Hemostats
  • Sponge Hemostats
  • Powder Hemostats

Segmentation 5: by Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest-of-the-World

Key Questions Answered in this Report:

  • What are the focus areas of the global hemostats market in the upcoming years?
  • What is the value of revenue generated from hemostats market across the globe and at what rate is the demand expected to grow during the forecast period?
  • Which product(s) is poised to be the primary revenue generator in the global hemostats market?
  • Among hemostats segments, which is projected to capture the largest market share?
  • In terms of applications, which segment is forecasted to experience the highest Compound Annual Growth Rate (CAGR) during the forecast period?
  • Which end-user segment accounted for the largest share of the hemostats market?
  • What are the key growth factors of this market? What are the major opportunities for existing market players and new entrants in the global hemostats market?
  • What are the major challenges faced by the existing players in the market?
  • Who are the major players dominating in the global hemostats market space?
  • Which regions/countries are expected to offer significant growth opportunities for the vendors operating in the hemostats market for the forecast period?

Table of Contents

Executive Summary

Scope and Definition

1. Markets

  • 1.1. Trends: Current and Future Impact Assessment
    • 1.1.1. Sample Text
    • 1.1.2. Trend 1
    • 1.1.3. Trend 2
    • 1.1.4. Trend 3
  • 1.2. Supply Chain Overview
    • 1.2.1. Value Chain Analysis
    • 1.2.2. Market Map
    • 1.2.3. Pricing Forecast for Raw Materials and Components
  • 1.3. Research and Development Review
    • 1.3.1. Patent Filing Trend (by Country, Company)
  • 1.4. Regulatory Landscape
  • 1.5. Impact Analysis for Key Global Events- Covid-19
  • 1.6. Market Dynamics Overview
    • 1.6.1. Market Drivers
    • 1.6.2. Market Restraints
    • 1.6.3. Market Opportunities

2. Application

  • 2.1. Application Segmentation
  • 2.2. Application Summary
  • 2.1. Global Hemostats Market (by Application)
    • 2.1.1. Cardiovascular Surgery
    • 2.1.2. General Surgery
    • 2.1.3. Gynecological Surgery
    • 2.1.4. Orthopedic Surgery
    • 2.1.5. Neurological Surgery
    • 2.1.6. Others
  • 2.2. Global Hemostats Market (by End User)
    • 2.2.1. Hospitals
    • 2.2.2. Ambulatory Surgical Centres
    • 2.2.3. Clinics and Physicans' Offices
    • 2.2.4. Others

3. Products

  • 3.1. Product Segmentation
  • 3.2. Product Summary
  • 3.3. Global Hemostats Market by Type
    • 3.3.1. Market Overview
      • 3.3.1.1. Analyst View
  • 3.1. Global Hemostats Market (by Type)
    • 3.1.1. Oxidized Regenerated Cellulose-Based Hemostats
    • 3.1.2. Thrombin Based Hemostats
    • 3.1.3. Combination Hemostats
    • 3.1.4. Gelatin-Based Hemostats
    • 3.1.5. Collagen-Based Hemostats
    • 3.1.6. Others
  • 3.2. Global Hemostats Market (by Formulation)
    • 3.2.1. Matrix and Gel Hemostats
    • 3.2.2. Sheet and Pad Hemostats
    • 3.2.3. Sponge Hemostats
    • 3.2.4. Powder Hemostats

4. Regions

  • 4.1. Regional Summary
  • 4.2. Drivers and Restraints
  • 4.3. North America
    • 4.3.1. Regional Overview
    • 4.3.2. Driving Factors for Market Growth
    • 4.3.3. Factors Challenging the Market
    • 4.3.4. Application
    • 4.3.5. Product
    • 4.3.6. U.S.
    • 4.3.7. U.S. Hemostats Market by Application
    • 4.3.8. Canada
    • 4.3.9. Canada Hemostats Market by Application
  • 4.4. Europe
    • 4.4.1. Regional Overview
    • 4.4.2. Driving Factors for Market Growth
    • 4.4.3. Factors Challenging the Market
    • 4.4.4. Application
    • 4.4.5. Product
    • 4.4.6. France
    • 4.4.7. France Hemostats Market by Application
    • 4.4.8. Germany
    • 4.4.9. Germany Hemostats Market by Application
    • 4.4.10. U.K.
    • 4.4.11. U.K. Hemostats Market by Application
    • 4.4.12. Italy
    • 4.4.13. Italy Hemostats Market by Application
    • 4.4.14. Spain
    • 4.4.15. Spain Hemostats Market by Application
    • 4.4.16. Rest of Europe
    • 4.4.17. Rest of Europe Hemostats Market by Application
  • 4.5. Asia Pacific
    • 4.5.1. Regional Overview
    • 4.5.2. Driving Factors for Market Growth
    • 4.5.3. Factors Challenging the Market
    • 4.5.1. Application
    • 4.5.2. Product
    • 4.5.3. China
    • 4.5.4. China Hemostats Market by Application
    • 4.5.5. India
    • 4.5.6. India Hemostats Market by Application
    • 4.5.7. Japan
    • 4.5.8. Japan Hemostats Market by Application
    • 4.5.9. Australia
    • 4.5.10. Australia Hemostats Market by Application
    • 4.5.11. Rest-of-Asia Pacific
    • 4.5.12. Rest-of-Asia Pacific Hemostats Market by Application
  • 4.6. Latin America
    • 4.6.1. Regional Overview
    • 4.6.2. Driving Factors for Market Growth
    • 4.6.3. Factors Challenging the Market
    • 4.6.4. Application
    • 4.6.5. Product
    • 4.6.6. Argentina
    • 4.6.7. Argentina Hemostats Market by Application
    • 4.6.8. Brazil
    • 4.6.9. Brazil Hemostats Market by Application
    • 4.6.10. Mexico
    • 4.6.11. Application
    • 4.6.12. Mexico Hemostats Market by Application
    • 4.6.13. Rest-of-Latin America
    • 4.6.14. Rest-of-Latin America Hemostats Market by Application
  • 4.7. Rest-of-the-World
    • 4.7.1. Regional Overview
    • 4.7.2. Driving Factors for Market Growth
    • 4.7.3. Factors Challenging the Market
    • 4.7.4. Application
    • 4.7.5. Product

5. Markets - Competitive Benchmarking & Company Profiles

  • 5.1. Next Frontiers…..
  • 5.2. Geographic Assessment
    • 5.2.1. Pfizer Inc. plc
      • 5.2.1.1. Overview
      • 5.2.1.2. Top Products / Product Portfolio
      • 5.2.1.3. Top Competitors
      • 5.2.1.4. Target Customers
      • 5.2.1.5. Key Personnel
      • 5.2.1.6. Analyst View
      • 5.2.1.7. Market Share
    • 5.2.2. Baxter International
      • 5.2.2.1. Overview
      • 5.2.2.2. Top Products / Product Portfolio
      • 5.2.2.3. Top Competitors
      • 5.2.2.4. Target Customers
      • 5.2.2.5. Key Personnel
      • 5.2.2.6. Analyst View
      • 5.2.2.7. Market Share
    • 5.2.3. B. Braun Holding GmbH & Co. KG
      • 5.2.3.1. Overview
      • 5.2.3.2. Top Products / Product Portfolio
      • 5.2.3.3. Top Competitors
      • 5.2.3.4. Target Customers
      • 5.2.3.5. Key Personnel
      • 5.2.3.6. Analyst View
      • 5.2.3.7. Market Share
    • 5.2.4. Teleflex Incorporated
      • 5.2.4.1. Overview
      • 5.2.4.2. Top Products / Product Portfolio
      • 5.2.4.3. Top Competitors
      • 5.2.4.4. Target Customers
      • 5.2.4.5. Key Personnel
      • 5.2.4.6. Analyst View
      • 5.2.4.7. Market Share
    • 5.2.5. Medtronic
      • 5.2.5.1. Overview
      • 5.2.5.2. Top Products / Product Portfolio
      • 5.2.5.3. Top Competitors
      • 5.2.5.4. Target Customers
      • 5.2.5.5. Key Personnel
      • 5.2.5.6. Analyst View
      • 5.2.5.7. Market Share
    • 5.2.6. Stryker Corporation
      • 5.2.6.1. Overview
      • 5.2.6.2. Top Products / Product Portfolio
      • 5.2.6.3. Top Competitors
      • 5.2.6.4. Target Customers
      • 5.2.6.5. Key Personnel
      • 5.2.6.6. Analyst View
      • 5.2.6.7. Market Share
    • 5.2.7. Boston Scientific Corporation
      • 5.2.7.1. Overview
      • 5.2.7.2. Top Products / Product Portfolio
      • 5.2.7.3. Top Competitors
      • 5.2.7.4. Target Customers
      • 5.2.7.5. Key Personnel
      • 5.2.7.6. Analyst View
      • 5.2.7.7. Market Share
    • 5.2.8. Samyang Holdings Corporation
      • 5.2.8.1. Overview
      • 5.2.8.2. Top Products / Product Portfolio
      • 5.2.8.3. Top Competitors
      • 5.2.8.4. Target Customers
      • 5.2.8.5. Key Personnel
      • 5.2.8.6. Analyst View
      • 5.2.8.7. Market Share
    • 5.2.9. Advanced Medical Solutions Group plc
      • 5.2.9.1. Overview
      • 5.2.9.2. Top Products / Product Portfolio
      • 5.2.9.3. Top Competitors
      • 5.2.9.4. Target Customers
      • 5.2.9.5. Key Personnel
      • 5.2.9.6. Analyst View
      • 5.2.9.7. Market Share
    • 5.2.10. Integra Life Sciences
      • 5.2.10.1. Overview
      • 5.2.10.2. Top Products / Product Portfolio
      • 5.2.10.3. Top Competitors
      • 5.2.10.4. Target Customers
      • 5.2.10.5. Key Personnel
      • 5.2.10.6. Analyst View
      • 5.2.10.7. Market Share
    • 5.2.11. Hemostasis, LLC.
      • 5.2.11.1. Overview
      • 5.2.11.2. Top Products / Product Portfolio
      • 5.2.11.3. Top Competitors
      • 5.2.11.4. Target Customers
      • 5.2.11.5. Key Personnel
      • 5.2.11.6. Analyst View
      • 5.2.11.7. Market Share
    • 5.2.12. Johnson and Johnson
      • 5.2.12.1. Overview
      • 5.2.12.2. Top Products / Product Portfolio
      • 5.2.12.3. Top Competitors
      • 5.2.12.4. Target Customers
      • 5.2.12.5. Key Personnel
      • 5.2.12.6. Analyst View
      • 5.2.12.7. Market Share
    • 5.2.13. Altaylar Medical
      • 5.2.13.1. Overview
      • 5.2.13.2. Top Products / Product Portfolio
      • 5.2.13.3. Top Competitors
      • 5.2.13.4. Target Customers
      • 5.2.13.5. Key Personnel
      • 5.2.13.6. Analyst View
      • 5.2.13.7. Market Share
    • 5.2.14. Anika Therapeutics, Inc.
      • 5.2.14.1. Overview
      • 5.2.14.2. Top Products / Product Portfolio
      • 5.2.14.3. Top Competitors
      • 5.2.14.4. Target Customers
      • 5.2.14.5. Key Personnel
      • 5.2.14.6. Analyst View
      • 5.2.14.7. Market Share
    • 5.2.15. Cryolife, Inc.
      • 5.2.15.1. Overview
      • 5.2.15.2. Top Products / Product Portfolio
      • 5.2.15.3. Top Competitors
      • 5.2.15.4. Target Customers
      • 5.2.15.5. Key Personnel
      • 5.2.15.6. Analyst View
      • 5.2.15.7. Market Share

6. Research Methodology

  • 6.1. Data Sources
    • 6.1.1. Primary Data Sources
    • 6.1.2. Secondary Data Sources
    • 6.1.3. Data Triangulation
  • 6.2. Market Estimation and Forecast